Literature DB >> 5655566

Lymphoid infiltrates in neuroblastomas: their occurrence and prognostic significance.

R F Martin, J B Beckwith.   

Abstract

Entities:  

Mesh：

Year:  1968        PMID： 5655566     DOI： 10.1016/0022-3468(68)91005-1

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN： 0022-3468            Impact factor:   2.545


× No keyword cloud information.
  14 in total

1.  Prognostic factors in neuroblastoma.

Authors:  R L Swank; G H Fetterman; W K Sieber; W B Kiesewetter
Journal:  Ann Surg       Date:  1971-09       Impact factor: 12.969

2.  Autoimmune reactions in uveal melanoma.

Authors:  A H Rahi
Journal:  Br J Ophthalmol       Date:  1971-12       Impact factor: 4.638

3.  Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma.

Authors:  Marco Mina; Renata Boldrini; Arianna Citti; Paolo Romania; Valerio D'Alicandro; Maretta De Ioris; Aurora Castellano; Cesare Furlanello; Franco Locatelli; Doriana Fruci
Journal:  Oncoimmunology       Date:  2015-04-02       Impact factor: 8.110

4.  Phenotypic characteristics of tumour-infiltrating lymphocytes in human oesophageal cancer tissues defined by quantitative two-colour analysis with flow-cytometry.

Authors:  H Tahara; H Shiozaki; K Kobayashi; T Yano; H Yano; S Tamura; K Oku; M Miyata; K Wakasa; M Sakurai
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 5.  Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis.

Authors:  J W Kreider; G L Bartlett; B L Butkiewicz
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

6.  Detection of bone marrow invasion by neuroblastoma is improved by sampling at two sites with both aspirates and trephine biopsies.

Authors:  I M Franklin; J Pritchard
Journal:  J Clin Pathol       Date:  1983-11       Impact factor: 3.411

7.  Recent advances in neuroblastoma.

Authors:  J Z Finklestein; G S Gilchrist
Journal:  Calif Med       Date:  1972-03

8.  Invariant natural killer T infiltration in neuroblastoma with favorable outcome.

Authors:  Tomoro Hishiki; Naoko Mise; Kazuaki Harada; Fumie Ihara; Mariko Takami; Takeshi Saito; Keita Terui; Mitsuyuki Nakata; Shugo Komatsu; Hideo Yoshida; Shinichiro Motohashi
Journal:  Pediatr Surg Int       Date:  2017-10-10       Impact factor: 1.827

9.  The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes.

Authors:  Lena-Maria Carlson; Anna De Geer; Baldur Sveinbjørnsson; Abiel Orrego; Tommy Martinsson; Per Kogner; Jelena Levitskaya
Journal:  Oncoimmunology       Date:  2013-03-01       Impact factor: 8.110

10.  Immunomodulatory monoclonal antibodies combined with peptide vaccination provide potent immunotherapy in an aggressive murine neuroblastoma model.

Authors:  Emily L Williams; Stuart N Dunn; Sonya James; Peter W Johnson; Mark S Cragg; Martin J Glennie; Juliet C Gray
Journal:  Clin Cancer Res       Date:  2013-05-06       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.